ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234740.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.014774501	Resistant
ENSG00000234740.1	ABT-263 (navitoclax)	Sarcoma	0.022022842	Resistant